A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

NCT ID: NCT05020236

The MagnetisMM-5 clinical trial is studying a new treatment option for people with relapsed or refractory multiple myeloma, a type of blood cancer. Researchers want to see if a medication called el...

Recruiting

Phase: PHASE3 Conditions: Multiple Myeloma

Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

NCT ID: NCT05317416

This clinical trial is studying a new treatment called elranatamab to see if it is more effective than a standard treatment called lenalidomide for patients with newly diagnosed multiple myeloma wh...

Recruiting

Phase: PHASE3 Conditions: Multiple Myeloma

A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab

NCT ID: NCT06880744

This clinical trial is looking at how well a medication called risankizumab works compared to another medication called vedolizumab in treating adults with moderate to severe ulcerative colitis (UC...

Recruiting

Phase: PHASE3 Conditions: Ulcerative Colitis

A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT ID: NCT05785767

This clinical trial is studying whether a new combination of two medications, fianlimab and cemiplimab, is more effective for treating advanced non-small cell lung cancer (NSCLC) than cemiplimab al...

Recruiting

Phase: PHASE2 Conditions: Advanced Non-Small Cell Lung Cancer

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

NCT ID: NCT06548542

This clinical trial is exploring new targeted therapies to treat adults with moderate to severe Crohn's Disease, a long-lasting condition that causes inflammation in the digestive tract and can lea...

Recruiting

Phase: PHASE2 Conditions: Crohn's Disease

A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery

NCT ID: NCT06161441

This clinical trial is investigating a new treatment for adults with a specific type of lung cancer called resectable non-small cell lung cancer (NSCLC), which means the cancer can be removed by su...

Recruiting

Phase: PHASE2 Conditions: Resectable Non-small Cell Lung Cancer

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

NCT ID: NCT06428019

This clinical trial is studying the safety and effectiveness of a medication called venetoclax when combined with two other treatments, obinutuzumab and acalabrutinib, for adults with chronic lymph...

Recruiting

Phase: PHASE3 Conditions: Chronic Lymphocytic Leukemia

A Trial to Learn if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

NCT ID: NCT06149286

This clinical trial is studying a new treatment for adults with two specific types of cancer: follicular lymphoma and marginal zone lymphoma, especially for those whose cancer has returned after tr...

Recruiting

Phase: PHASE3 Conditions: Marginal Zone Lymphoma (MZL), Relapsed/Refractory Follicular Lymphoma

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

NCT ID: NCT06282575

This clinical trial is investigating a new treatment approach for patients with advanced biliary tract cancer that has a specific gene mutation called HER2. The study is looking at how effective an...

Recruiting

Phase: PHASE3 Conditions: Biliary Tract Cancer

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

NCT ID: NCT06107426

This clinical trial is studying the effectiveness of a medication called ABBV-951 for treating adults with advanced Parkinson's disease (PD). Parkinson's disease is a condition that affects the bra...

Recruiting

Conditions: Parkinson's Disease (PD)

Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

NCT ID: NCT05911295

This clinical trial is studying two different treatment options for patients with urothelial cancer, which can affect the bladder, kidneys, or urinary tubes. The researchers want to find out if a c...

Recruiting

Phase: PHASE3 Conditions: Urothelial Carcinoma

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

NCT ID: NCT05407636

The Pivotal 2 Study is investigating a new gene therapy called ABBV-RGX-314 for people with wet age-related macular degeneration (wet AMD). This condition causes vision loss due to the growth of ab...

Recruiting

Phase: PHASE3 Conditions: AMD, Wet Age-related Macular Degeneration +4 more

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

NCT ID: NCT04590326

This clinical trial is looking at a new drug called REGN5668 to see how safe it is and how well it works when combined with other treatments for cancers like ovarian cancer, fallopian tube cancer, ...

Recruiting

Phase: PHASE1 Conditions: Ovarian Cancer, Endometrial Cancer +2 more

Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

NCT ID: NCT06236438

This clinical trial is studying a new treatment approach for adults with untreated metastatic non-squamous non-small cell lung cancer (NSCLC), which is a serious type of lung cancer. Researchers wa...

Recruiting

Phase: PHASE2 Conditions: Non-Small Cell Lung Cancer

A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

NCT ID: NCT05976243

This clinical trial is studying a medication called remibrutinib to see if it helps adults with a condition known as Chronic Inducible Urticaria (CINDU), which causes sudden skin reactions like hiv...

Recruiting

Phase: PHASE3 Conditions: Chronic Inducible Urticaria

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

NCT ID: NCT05730036

This clinical trial is studying a new drug called linvoseltamab to see how well it works for adults with relapsed or refractory multiple myeloma—a type of blood cancer that has come back after trea...

Recruiting

Phase: PHASE3 Conditions: Relapsed Refractory Multiple Myeloma (RRMM)

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma

NCT ID: NCT06091254

This clinical trial is studying a new experimental drug called odronextamab to see if it is safe and effective for people with follicular lymphoma, a type of blood cancer. The trial has two parts: ...

Recruiting

Phase: PHASE3 Conditions: Follicular Lymphoma (FL)

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

NCT ID: NCT05287126

This clinical trial is studying a medication called etrasimod to see how safe and effective it is for treating moderately to severely active ulcerative colitis in adolescents aged 12 to under 18 ye...

Recruiting

Phase: PHASE2 Conditions: Ulcerative Colitis

Observational Study Protocol: LIVER-R

NCT ID: NCT06252753

The LIVER-R study is a clinical trial aimed at understanding how effective a treatment called durvalumab is for patients with certain types of liver and bile duct cancers. This study will gather in...

Recruiting

Conditions: Hepatobiliary Cancers

Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.

NCT ID: NCT06099119

This clinical trial is studying the effects of a treatment called Pancreatic Exocrine Replacement Therapy (PERT) on patients with unresectable pancreatic cancer, which means that the cancer cannot ...

Recruiting

Phase: PHASE4 Conditions: Unresectable Pancreatic Cancer

Main Menu

Clinical Trials in Santiago De Compostela, A Coruna

23 Active Trials Found in Santiago De Compostela

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab

A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

A Trial to Learn if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

Observational Study Protocol: LIVER-R

Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.